Key result
TUG-891 mitigates vascular remodeling in mice by reducing lipolysis and suppressing aberrant adipocyte browning.
Its licence doesn't allow us to show a copy here.
Why the study?
Free fatty acid receptor 4 activation modulates adipogenesis, but its role in perivascular adipose tissue dysfunction and vascular remodeling had not been explored.
Does TUG-891-mediated FFAR4 activation prevent vascular remodeling in high-fat diet-fed mice?
Does TUG-891-mediated FFAR4 activation prevent vascular remodeling in high-fat diet-fed mice?
TUG-891 mitigates vascular hyperplasia and remodeling by activating FFAR4 in perivascular adipose tissue, highlighting a potential therapeutic target for vascular diseases.
Answers are grounded in this paper and cite their sources.
Identifies perivascular FFAR4 as a target for vascular remodeling; leaves open translation from mouse models to patients.
BACKGROUND: Free fatty acid receptor 4 (FFAR4) activation modulates adipogenesis, but this pathway has not been explored in the context of perivascular adipose tissue (PVAT) dysfunction and vascular remodeling. RESULTS: FFAR4 was particularly upregulated in abdominal aortic PVAT in response to high-fat diet. TUG-891-mediated FFAR4 activation in PVAT alleviated abdominal aortic dysfunction and hyperplasia in WT mice. TUG-891 also prohibited aberrant lipolysis and browning, as evidenced by lower serum FFA levels and downregulated UCP1 expression, in a FFAR4-dependent manner. Expression of pro-remodeling genes (CCL2, MMP9, SPP1) in damaged PVAT was reduced by TUG-891. These protective effects were absent in Adipo-KO mice. In vitro, conditioned medium from FeCl₃-primed PVAT promoted VSMC proliferation and migration, which was attenuated by TUG-891 in the presence of FFAR4. Free fatty acids also enhanced VSMC proliferation and migration. These effects were abolished when using PVAT or cells from Adipo-KO mice. CONCLUSION: These results indicate that TUG-891 mitigates vascular hyperplasia and remodeling by activating FFAR4 in PVAT, reducing lipolysis and suppressing aberrant adipocyte browning. Targeting PVAT FFAR4 signaling may represent a promising therapeutic strategy for vascular diseases.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied Vascular remodeling and perivascular adipose tissue dysfunction. TUG-891 vs. Adipo-KO mice / untreated was evaluated on Vascular hyperplasia and remodeling. TUG-891-mediated FFAR4 activation in perivascular adipose tissue mitigated vascular hyperplasia and remodeling by reducing lipolysis and suppressing aberrant adipocyte browning in mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: